Created in 1991 (Switzerland), SANDIMMUN NEORAL own 2951 sister brands and 17477 competing brands. SANDIMMUN NEORAL is owned by NOVARTIS N, listed on the stock exchange of Zurich The International Securities Identification Number (ISIN) of NOVARTIS N is CH0012005267. SANDIMMUN NEORAL belongs to the Drug Manufacturers business sector.
Share price and profitability of the share NOVARTIS N (SANDIMMUN NEORAL)
Buy NOVARTIS N share with
(0% commission and fractional shares)
Your capital is subject to risk. Other fees apply. For more information, visit etoro.com/trading/fees.
Investment simulator :
Portfolio valuation
NOVARTIS N
(SANDIMMUN NEORAL)
over 5 years*
CHF 101.63
Stock market history NOVARTIS N (SANDIMMUN NEORAL)
*non inclusive of dividends, non inclusive of market orders
past performances do not prejudice future performances
past performances do not prejudice future performances
